Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    What AstraZeneca plc’s Investment Plans Mean For Earnings Growth

    | Royston Wild

    Royston Wild evaluates what AstraZeneca plc's (LON: AZN) capex drive is likely to mean for future earnings.

    Read more »

    Investing Articles

    GlaxoSmithKline plc Stumbles But It’s Still A Buy

    | Tony Reading

    Drug setbacks highlight GlaxoSmithKline plc's (LON:GSK) robustness

    Read more »

    Investing Videos

    GlaxoSmithKline plc vs AstraZeneca plc: Where Would You Put Your Money?

    | Mark Stones

    VIDEO: Two Fools put GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN).

    Read more »

    Investing Articles

    AstraZeneca plc: The ‘Sell’ That Has Been A Great ‘Buy’

    | Harvey Jones

    Analysts who damned AstraZeneca plc (LON: AZN) as a Sell missed a great Buy. So why are brokers still calling…

    Read more »

    Investing Articles

    AstraZeneca Plc After The Patent Cliff

    | Prabhat Sakya

    AstraZeneca plc (LON:AZN) is set to recover strongly according to one Fool.

    Read more »

    Investing Articles

    3 Reasons To Dump AstraZeneca plc For GlaxoSmithKline plc

    | Rupert Hargreaves

    AstraZeneca plc's (LON: AZN) recent rally has been impressive but it could be time to sell out in favour of…

    Read more »

    Investing Articles

    Is AstraZeneca plc A Super Income Stock?

    | Peter Stephens

    Does AstraZeneca plc (LON: AZN) have the right credentials to be classed as a very attractive income play?

    Read more »

    Investing Articles

    How Safe Is Your Money In AstraZeneca plc?

    | Roland Head

    As profits continue to fall at AstraZeneca plc (LON:AZN), is the firm's dividend safe or could it come under threat?

    Read more »

    Investing Articles

    The Reasons AstraZeneca plc Won’t Make You Wealthy

    | Mark Stones

    Why I wouldn't make AstraZeneca plc (LON: AZN) a core share in my portfolio.

    Read more »

    Investing Articles

    The Contrary Investment Case: 3 Reasons To Stock Up On AstraZeneca plc

    | Royston Wild

    Royston Wild looks at why AstraZeneca plc (LON: AZN) could be a canny share purchase.

    Read more »

    Investing Articles

    Why AstraZeneca plc Should Be A Candidate For Your 2014 ISA

    | Alan Oscroft

    AstraZeneca plc (LON: AZN) is heading back to growth.

    Read more »

    Investing Articles

    Should You Dump AstraZeneca plc In Favour Of GlaxoSmithKline plc?

    | Rupert Hargreaves

    AstraZeneca plc (LON: AZN) currently trades at a premium to GlaxoSmithKline plc (LON: GSK); does it deserve it?

    Read more »